The global market for GLP-1 receptor agonists is witnessing a surge in demand due to their efficacy in managing type 2 diabetes. Several leading companies have earned FDA approval to develop these life-changing medications. {Novo Nordisk|Ascensia Pharmaare a leading developer of GLP-1 receptor agonists, with proven products like Rybelsus. {Sa